(Q35087541)

6 August 2017

1 reference

title

Antiobesity drugs: current and future issues (English)

1 reference

6 August 2017

M Ammar Hatahet

1

1 reference

6 August 2017

Nikhil V Dhurandhar

series ordinal

2

1 reference

6 August 2017

publication date

1 October 2002

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

409-415

1 reference

Economic costs of obesity and inactivity

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0105-3

Use of prescription weight loss pills among U.S. adults in 1996-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0105-3

Fluoxetine: a randomized clinical trial in the maintenance of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0105-3

Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0105-3

Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0105-3

Early leptin response to a palatable diet predicts dietary obesity in rats: key role of melanocortin-4 receptors in the ventromedial hypothalamic nucleus

21 January 2018

1 reference

12 December 2020

Anorectic drugs and valvular heart disease: a biological and clinical perspective

1 reference

12 December 2020

Nutritional regulation of leptin in humans

1 reference

12 December 2020

Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines

1 reference

12 December 2020

Sibutramine. A review of its contribution to the management of obesity.

1 reference

12 December 2020

Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract.

1 reference

12 December 2020

Weight-reducing effects of the plasma protein encoded by the obese gene

1 reference

12 December 2020

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

1 reference

12 December 2020

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

12 December 2020

Ghrelin strongly stimulates growth hormone release in humans

1 reference

12 December 2020

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

1 reference

12 December 2020

Treatment of binge-eating disorder with topiramate: a clinical case series

1 reference

12 December 2020

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

1 reference

12 December 2020

Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity

1 reference

12 December 2020

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

1 reference

12 December 2020

Effects of bupropion on body weight.

1 reference

12 December 2020

Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

1 reference

12 December 2020

Obesity drugs and the heart

1 reference

12 December 2020

Treatment of affective disorder and obesity with topiramate

1 reference

12 December 2020

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

1 reference

12 December 2020

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

1 reference

12 December 2020

Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.

1 reference

12 December 2020

Fluoxetine's effect on weight loss in obese subjects

1 reference

12 December 2020

Fluoxetine: a randomized clinical trial in the treatment of obesity

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Phenylpropanolamine in drugs could be a risk for stroke

1 reference

12 December 2020

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

1 reference

12 December 2020

Circulating ghrelin levels are decreased in human obesity.

1 reference

12 December 2020

A pharmacological and clinical review on topiramate, a new antiepileptic drug

1 reference

12 December 2020

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

12 December 2020

Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture

1 reference

12 December 2020

Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men.

1 reference

12 December 2020

Ghrelin enhances appetite and increases food intake in humans

1 reference

12 December 2020

Valvular heart disease associated with fenfluramine-phentermine

1 reference

12 December 2020

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

12 December 2020

Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans

1 reference

12 December 2020

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

12 December 2020

Topiramate use in obese patients with binge eating disorder: an open study.

1 reference

12 December 2020

Fen-phen and risk of valvular disease

1 reference

12 December 2020

The continuing epidemics of obesity and diabetes in the United States

1 reference

12 December 2020

Comparison of continuous and intermittent anorectic therapy in obesity

1 reference

12 December 2020

High glycemic index carbohydrate diet alters the diurnal rhythm of leptin but not insulin concentrations

1 reference

12 December 2020

Abuse liability assessment of sibutramine, a novel weight control agent

1 reference

12 December 2020

Bupropion: a review of its mechanism of antidepressant activity

1 reference

12 December 2020

Weight loss increases circulating levels of ghrelin in human obesity

1 reference

12 December 2020

Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series

1 reference

12 December 2020

Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.

1 reference

12 December 2020

A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation

1 reference

12 December 2020

Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats

1 reference

12 December 2020

Leptin, the hypothalamus and the regulation of adiposity

1 reference

12 December 2020

Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid)

1 reference

12 December 2020

Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure

1 reference

12 December 2020

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

1 reference

12 December 2020

1 reference

12 December 2020

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

12 December 2020

Phenylpropanolamine and the risk of hemorrhagic stroke

1 reference

12 December 2020

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

1 reference

12 December 2020

Long-term weight loss with sibutramine: a randomized controlled trial

1 reference

12 December 2020

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

1 reference

12 December 2020

Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats

1 reference

12 December 2020

10.1007/S11892-002-0105-3

Identifiers

DOI

1 reference

6 August 2017

1 reference